aluates Reports

$ 0.0

Automative

Global Thrombopoiesis Stimulating Agents Market Research Report 2025

Published Date: May 2025

Report Code: QYRE-Auto-33N18582

Thrombopoiesis Stimulating Agents Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

BUY CHAPTERS

Global Thrombopoiesis Stimulating Agents Market Research Report 2025

Code: QYRE-Auto-33N18582

Report

May 2025

Pages:85

QYResearch

Buy Now with 15% Discount

DESCRIPTION

TABLE OF CONTENT

TABLES & FIGURES

FEATURED COMPANIES

Kyowa Kirin

Intas Pharmaceuticals

Shionogi

Novartis Pharma

AkaRx Inc

Rigel Pharmaceuticals

Kissei Pharmaceutical

Grifols S A

JW Pharmaceutical Corporation

Medison Pharma Canada

Astrazeneca plc

Thrombopoiesis Stimulating Agents Market

The global market for Thrombopoiesis Stimulating Agents was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.

North American market for Thrombopoiesis Stimulating Agents is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

Asia-Pacific market for Thrombopoiesis Stimulating Agents is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

The global market for Thrombopoiesis Stimulating Agents in Adults is estimated to increase from $ million in 2024 to $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

The major global companies of Thrombopoiesis Stimulating Agents include Amgen, Kyowa Kirin, Intas Pharmaceuticals, SHIONOGI, Novartis Pharma, AkaRx, Rigel Pharmaceuticals, Kissei Pharmaceutical, Grifols, JW Pharmaceutical Corporation, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.

This report aims to provide a comprehensive presentation of the global market for Thrombopoiesis Stimulating Agents, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Thrombopoiesis Stimulating Agents.

The Thrombopoiesis Stimulating Agents market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Thrombopoiesis Stimulating Agents market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Thrombopoiesis Stimulating Agents companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

Scope of Thrombopoiesis Stimulating Agents Market Report

Report Metric	Details
Report Name	Thrombopoiesis Stimulating Agents Market
Segment by Type	Romiplostim Fostamatinib Mulpleta Doptelet Others
Segment by Application	Adults Pediatric Patients
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Amgen, Kyowa Kirin, Intas Pharmaceuticals, SHIONOGI, Novartis Pharma, AkaRx, Rigel Pharmaceuticals, Kissei Pharmaceutical, Grifols, JW Pharmaceutical Corporation, Medison Pharma Canada, AstraZeneca
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Thrombopoiesis Stimulating Agents company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the Thrombopoiesis Stimulating Agents Market report?

Ans: The main players in the Thrombopoiesis Stimulating Agents Market are Amgen, Kyowa Kirin, Intas Pharmaceuticals, SHIONOGI, Novartis Pharma, AkaRx, Rigel Pharmaceuticals, Kissei Pharmaceutical, Grifols, JW Pharmaceutical Corporation, Medison Pharma Canada, AstraZeneca

What are the Application segmentation covered in the Thrombopoiesis Stimulating Agents Market report?

Ans: The Applications covered in the Thrombopoiesis Stimulating Agents Market report are Adults, Pediatric Patients

What are the Type segmentation covered in the Thrombopoiesis Stimulating Agents Market report?

Ans: The Types covered in the Thrombopoiesis Stimulating Agents Market report are Romiplostim, Fostamatinib, Mulpleta, Doptelet, Others

Recommended Reports

Blood Disorders Therapy

Cell And Gene Therapy

Medical Devices Therapy

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Thrombopoiesis Stimulating Agents Market Size Growth Rate by Type: 2020 VS 2024 VS 2031

1.2.2 Romiplostim

1.2.3 Fostamatinib

1.2.4 Mulpleta

1.2.5 Doptelet

1.2.6 Others

1.3 Market by Application

1.3.1 Global Thrombopoiesis Stimulating Agents Market Growth by Application: 2020 VS 2024 VS 2031

1.3.2 Adults

1.3.3 Pediatric Patients

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Global Growth Trends

2.1 Global Thrombopoiesis Stimulating Agents Market Perspective (2020-2031)

2.2 Global Thrombopoiesis Stimulating Agents Growth Trends by Region

2.2.1 Global Thrombopoiesis Stimulating Agents Market Size by Region: 2020 VS 2024 VS 2031

2.2.2 Thrombopoiesis Stimulating Agents Historic Market Size by Region (2020-2025)

2.2.3 Thrombopoiesis Stimulating Agents Forecasted Market Size by Region (2026-2031)

2.3 Thrombopoiesis Stimulating Agents Market Dynamics

2.3.1 Thrombopoiesis Stimulating Agents Industry Trends

2.3.2 Thrombopoiesis Stimulating Agents Market Drivers

2.3.3 Thrombopoiesis Stimulating Agents Market Challenges

2.3.4 Thrombopoiesis Stimulating Agents Market Restraints

3 Competition Landscape by Key Players

3.1 Global Top Thrombopoiesis Stimulating Agents Players by Revenue

3.1.1 Global Top Thrombopoiesis Stimulating Agents Players by Revenue (2020-2025)

3.1.2 Global Thrombopoiesis Stimulating Agents Revenue Market Share by Players (2020-2025)

3.2 Global Thrombopoiesis Stimulating Agents Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Global Key Players Ranking by Thrombopoiesis Stimulating Agents Revenue

3.4 Global Thrombopoiesis Stimulating Agents Market Concentration Ratio

3.4.1 Global Thrombopoiesis Stimulating Agents Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Thrombopoiesis Stimulating Agents Revenue in 2024

3.5 Global Key Players of Thrombopoiesis Stimulating Agents Head office and Area Served

3.6 Global Key Players of Thrombopoiesis Stimulating Agents, Product and Application

3.7 Global Key Players of Thrombopoiesis Stimulating Agents, Date of Enter into This Industry

3.8 Mergers & Acquisitions, Expansion Plans

4 Thrombopoiesis Stimulating Agents Breakdown Data by Type

4.1 Global Thrombopoiesis Stimulating Agents Historic Market Size by Type (2020-2025)

4.2 Global Thrombopoiesis Stimulating Agents Forecasted Market Size by Type (2026-2031)

5 Thrombopoiesis Stimulating Agents Breakdown Data by Application

5.1 Global Thrombopoiesis Stimulating Agents Historic Market Size by Application (2020-2025)

5.2 Global Thrombopoiesis Stimulating Agents Forecasted Market Size by Application (2026-2031)

6 North America

6.1 North America Thrombopoiesis Stimulating Agents Market Size (2020-2031)

6.2 North America Thrombopoiesis Stimulating Agents Market Growth Rate by Country: 2020 VS 2024 VS 2031

6.3 North America Thrombopoiesis Stimulating Agents Market Size by Country (2020-2025)

6.4 North America Thrombopoiesis Stimulating Agents Market Size by Country (2026-2031)

6.5 United States

6.6 Canada

7 Europe

7.1 Europe Thrombopoiesis Stimulating Agents Market Size (2020-2031)

7.2 Europe Thrombopoiesis Stimulating Agents Market Growth Rate by Country: 2020 VS 2024 VS 2031

7.3 Europe Thrombopoiesis Stimulating Agents Market Size by Country (2020-2025)

7.4 Europe Thrombopoiesis Stimulating Agents Market Size by Country (2026-2031)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Nordic Countries

8 Asia-Pacific

8.1 Asia-Pacific Thrombopoiesis Stimulating Agents Market Size (2020-2031)

8.2 Asia-Pacific Thrombopoiesis Stimulating Agents Market Growth Rate by Region: 2020 VS 2024 VS 2031

8.3 Asia-Pacific Thrombopoiesis Stimulating Agents Market Size by Region (2020-2025)

8.4 Asia-Pacific Thrombopoiesis Stimulating Agents Market Size by Region (2026-2031)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia

9 Latin America

9.1 Latin America Thrombopoiesis Stimulating Agents Market Size (2020-2031)

9.2 Latin America Thrombopoiesis Stimulating Agents Market Growth Rate by Country: 2020 VS 2024 VS 2031

9.3 Latin America Thrombopoiesis Stimulating Agents Market Size by Country (2020-2025)

9.4 Latin America Thrombopoiesis Stimulating Agents Market Size by Country (2026-2031)

9.5 Mexico

9.6 Brazil

10 Middle East & Africa

10.1 Middle East & Africa Thrombopoiesis Stimulating Agents Market Size (2020-2031)

10.2 Middle East & Africa Thrombopoiesis Stimulating Agents Market Growth Rate by Country: 2020 VS 2024 VS 2031

10.3 Middle East & Africa Thrombopoiesis Stimulating Agents Market Size by Country (2020-2025)

10.4 Middle East & Africa Thrombopoiesis Stimulating Agents Market Size by Country (2026-2031)

10.5 Turkey

10.6 Saudi Arabia

10.7 UAE

11 Key Players Profiles

11.1 Amgen

11.1.1 Amgen Company Details

11.1.2 Amgen Business Overview

11.1.3 Amgen Thrombopoiesis Stimulating Agents Introduction

11.1.4 Amgen Revenue in Thrombopoiesis Stimulating Agents Business (2020-2025)

11.1.5 Amgen Recent Development

11.2 Kyowa Kirin

11.2.1 Kyowa Kirin Company Details

11.2.2 Kyowa Kirin Business Overview

11.2.3 Kyowa Kirin Thrombopoiesis Stimulating Agents Introduction

11.2.4 Kyowa Kirin Revenue in Thrombopoiesis Stimulating Agents Business (2020-2025)

11.2.5 Kyowa Kirin Recent Development

11.3 Intas Pharmaceuticals

11.3.1 Intas Pharmaceuticals Company Details

11.3.2 Intas Pharmaceuticals Business Overview

11.3.3 Intas Pharmaceuticals Thrombopoiesis Stimulating Agents Introduction

11.3.4 Intas Pharmaceuticals Revenue in Thrombopoiesis Stimulating Agents Business (2020-2025)

11.3.5 Intas Pharmaceuticals Recent Development

11.4 SHIONOGI

11.4.1 SHIONOGI Company Details

11.4.2 SHIONOGI Business Overview

11.4.3 SHIONOGI Thrombopoiesis Stimulating Agents Introduction

11.4.4 SHIONOGI Revenue in Thrombopoiesis Stimulating Agents Business (2020-2025)

11.4.5 SHIONOGI Recent Development

11.5 Novartis Pharma

11.5.1 Novartis Pharma Company Details

11.5.2 Novartis Pharma Business Overview

11.5.3 Novartis Pharma Thrombopoiesis Stimulating Agents Introduction

11.5.4 Novartis Pharma Revenue in Thrombopoiesis Stimulating Agents Business (2020-2025)

11.5.5 Novartis Pharma Recent Development

11.6 AkaRx

11.6.1 AkaRx Company Details

11.6.2 AkaRx Business Overview

11.6.3 AkaRx Thrombopoiesis Stimulating Agents Introduction

11.6.4 AkaRx Revenue in Thrombopoiesis Stimulating Agents Business (2020-2025)

11.6.5 AkaRx Recent Development

11.7 Rigel Pharmaceuticals

11.7.1 Rigel Pharmaceuticals Company Details

11.7.2 Rigel Pharmaceuticals Business Overview

11.7.3 Rigel Pharmaceuticals Thrombopoiesis Stimulating Agents Introduction

11.7.4 Rigel Pharmaceuticals Revenue in Thrombopoiesis Stimulating Agents Business (2020-2025)

11.7.5 Rigel Pharmaceuticals Recent Development

11.8 Kissei Pharmaceutical

11.8.1 Kissei Pharmaceutical Company Details

11.8.2 Kissei Pharmaceutical Business Overview

11.8.3 Kissei Pharmaceutical Thrombopoiesis Stimulating Agents Introduction

11.8.4 Kissei Pharmaceutical Revenue in Thrombopoiesis Stimulating Agents Business (2020-2025)

11.8.5 Kissei Pharmaceutical Recent Development

11.9 Grifols

11.9.1 Grifols Company Details

11.9.2 Grifols Business Overview

11.9.3 Grifols Thrombopoiesis Stimulating Agents Introduction

11.9.4 Grifols Revenue in Thrombopoiesis Stimulating Agents Business (2020-2025)

11.9.5 Grifols Recent Development

11.10 JW Pharmaceutical Corporation

11.10.1 JW Pharmaceutical Corporation Company Details

11.10.2 JW Pharmaceutical Corporation Business Overview

11.10.3 JW Pharmaceutical Corporation Thrombopoiesis Stimulating Agents Introduction

11.10.4 JW Pharmaceutical Corporation Revenue in Thrombopoiesis Stimulating Agents Business (2020-2025)

11.10.5 JW Pharmaceutical Corporation Recent Development

11.11 Medison Pharma Canada

11.11.1 Medison Pharma Canada Company Details

11.11.2 Medison Pharma Canada Business Overview

11.11.3 Medison Pharma Canada Thrombopoiesis Stimulating Agents Introduction

11.11.4 Medison Pharma Canada Revenue in Thrombopoiesis Stimulating Agents Business (2020-2025)

11.11.5 Medison Pharma Canada Recent Development

11.12 AstraZeneca

11.12.1 AstraZeneca Company Details

11.12.2 AstraZeneca Business Overview

11.12.3 AstraZeneca Thrombopoiesis Stimulating Agents Introduction

11.12.4 AstraZeneca Revenue in Thrombopoiesis Stimulating Agents Business (2020-2025)

11.12.5 AstraZeneca Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.1.1 Research Programs/Design

13.1.1.2 Market Size Estimation

13.1.1.3 Market Breakdown and Data Triangulation

13.1.2 Data Source

13.1.2.1 Secondary Sources

13.1.2.2 Primary Sources

13.2 Author Details

13.3 Disclaimer

FEATURED COMPANIES

Kyowa Kirin

Intas Pharmaceuticals

Shionogi

Novartis Pharma

AkaRx Inc

Rigel Pharmaceuticals

Kissei Pharmaceutical

Grifols S A

JW Pharmaceutical Corporation

Medison Pharma Canada

Astrazeneca plc

List of Tables

Table 1. Global Thrombopoiesis Stimulating Agents Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031

Table 2. Key Players of Romiplostim

Table 3. Key Players of Fostamatinib

Table 4. Key Players of Mulpleta

Table 5. Key Players of Doptelet

Table 6. Key Players of Others

Table 7. Global Thrombopoiesis Stimulating Agents Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031

Table 8. Global Thrombopoiesis Stimulating Agents Market Size by Region (US$ Million): 2020 VS 2024 VS 2031

Table 9. Global Thrombopoiesis Stimulating Agents Market Size by Region (2020-2025) & (US$ Million)

Table 10. Global Thrombopoiesis Stimulating Agents Market Share by Region (2020-2025)

Table 11. Global Thrombopoiesis Stimulating Agents Forecasted Market Size by Region (2026-2031) & (US$ Million)

Table 12. Global Thrombopoiesis Stimulating Agents Market Share by Region (2026-2031)

Table 13. Thrombopoiesis Stimulating Agents Market Trends

Table 14. Thrombopoiesis Stimulating Agents Market Drivers

Table 15. Thrombopoiesis Stimulating Agents Market Challenges

Table 16. Thrombopoiesis Stimulating Agents Market Restraints

Table 17. Global Thrombopoiesis Stimulating Agents Revenue by Players (2020-2025) & (US$ Million)

Table 18. Global Thrombopoiesis Stimulating Agents Market Share by Players (2020-2025)

Table 19. Global Top Thrombopoiesis Stimulating Agents Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Thrombopoiesis Stimulating Agents as of 2024)

Table 20. Ranking of Global Top Thrombopoiesis Stimulating Agents Companies by Revenue (US$ Million) in 2024

Table 21. Global 5 Largest Players Market Share by Thrombopoiesis Stimulating Agents Revenue (CR5 and HHI) & (2020-2025)

Table 22. Global Key Players of Thrombopoiesis Stimulating Agents, Headquarters and Area Served

Table 23. Global Key Players of Thrombopoiesis Stimulating Agents, Product and Application

Table 24. Global Key Players of Thrombopoiesis Stimulating Agents, Date of Enter into This Industry

Table 25. Mergers & Acquisitions, Expansion Plans

Table 26. Global Thrombopoiesis Stimulating Agents Market Size by Type (2020-2025) & (US$ Million)

Table 27. Global Thrombopoiesis Stimulating Agents Revenue Market Share by Type (2020-2025)

Table 28. Global Thrombopoiesis Stimulating Agents Forecasted Market Size by Type (2026-2031) & (US$ Million)

Table 29. Global Thrombopoiesis Stimulating Agents Revenue Market Share by Type (2026-2031)

Table 30. Global Thrombopoiesis Stimulating Agents Market Size by Application (2020-2025) & (US$ Million)

Table 31. Global Thrombopoiesis Stimulating Agents Revenue Market Share by Application (2020-2025)

Table 32. Global Thrombopoiesis Stimulating Agents Forecasted Market Size by Application (2026-2031) & (US$ Million)

Table 33. Global Thrombopoiesis Stimulating Agents Revenue Market Share by Application (2026-2031)

Table 34. North America Thrombopoiesis Stimulating Agents Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 35. North America Thrombopoiesis Stimulating Agents Market Size by Country (2020-2025) & (US$ Million)

Table 36. North America Thrombopoiesis Stimulating Agents Market Size by Country (2026-2031) & (US$ Million)

Table 37. Europe Thrombopoiesis Stimulating Agents Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 38. Europe Thrombopoiesis Stimulating Agents Market Size by Country (2020-2025) & (US$ Million)

Table 39. Europe Thrombopoiesis Stimulating Agents Market Size by Country (2026-2031) & (US$ Million)

Table 40. Asia-Pacific Thrombopoiesis Stimulating Agents Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031

Table 41. Asia-Pacific Thrombopoiesis Stimulating Agents Market Size by Region (2020-2025) & (US$ Million)

Table 42. Asia-Pacific Thrombopoiesis Stimulating Agents Market Size by Region (2026-2031) & (US$ Million)

Table 43. Latin America Thrombopoiesis Stimulating Agents Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 44. Latin America Thrombopoiesis Stimulating Agents Market Size by Country (2020-2025) & (US$ Million)

Table 45. Latin America Thrombopoiesis Stimulating Agents Market Size by Country (2026-2031) & (US$ Million)

Table 46. Middle East & Africa Thrombopoiesis Stimulating Agents Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 47. Middle East & Africa Thrombopoiesis Stimulating Agents Market Size by Country (2020-2025) & (US$ Million)

Table 48. Middle East & Africa Thrombopoiesis Stimulating Agents Market Size by Country (2026-2031) & (US$ Million)

Table 49. Amgen Company Details

Table 50. Amgen Business Overview

Table 51. Amgen Thrombopoiesis Stimulating Agents Product

Table 52. Amgen Revenue in Thrombopoiesis Stimulating Agents Business (2020-2025) & (US$ Million)

Table 53. Amgen Recent Development

Table 54. Kyowa Kirin Company Details

Table 55. Kyowa Kirin Business Overview

Table 56. Kyowa Kirin Thrombopoiesis Stimulating Agents Product

Table 57. Kyowa Kirin Revenue in Thrombopoiesis Stimulating Agents Business (2020-2025) & (US$ Million)

Table 58. Kyowa Kirin Recent Development

Table 59. Intas Pharmaceuticals Company Details

Table 60. Intas Pharmaceuticals Business Overview

Table 61. Intas Pharmaceuticals Thrombopoiesis Stimulating Agents Product

Table 62. Intas Pharmaceuticals Revenue in Thrombopoiesis Stimulating Agents Business (2020-2025) & (US$ Million)

Table 63. Intas Pharmaceuticals Recent Development

Table 64. SHIONOGI Company Details

Table 65. SHIONOGI Business Overview

Table 66. SHIONOGI Thrombopoiesis Stimulating Agents Product

Table 67. SHIONOGI Revenue in Thrombopoiesis Stimulating Agents Business (2020-2025) & (US$ Million)

Table 68. SHIONOGI Recent Development

Table 69. Novartis Pharma Company Details

Table 70. Novartis Pharma Business Overview

Table 71. Novartis Pharma Thrombopoiesis Stimulating Agents Product

Table 72. Novartis Pharma Revenue in Thrombopoiesis Stimulating Agents Business (2020-2025) & (US$ Million)

Table 73. Novartis Pharma Recent Development

Table 74. AkaRx Company Details

Table 75. AkaRx Business Overview

Table 76. AkaRx Thrombopoiesis Stimulating Agents Product

Table 77. AkaRx Revenue in Thrombopoiesis Stimulating Agents Business (2020-2025) & (US$ Million)

Table 78. AkaRx Recent Development

Table 79. Rigel Pharmaceuticals Company Details

Table 80. Rigel Pharmaceuticals Business Overview

Table 81. Rigel Pharmaceuticals Thrombopoiesis Stimulating Agents Product

Table 82. Rigel Pharmaceuticals Revenue in Thrombopoiesis Stimulating Agents Business (2020-2025) & (US$ Million)

Table 83. Rigel Pharmaceuticals Recent Development

Table 84. Kissei Pharmaceutical Company Details

Table 85. Kissei Pharmaceutical Business Overview

Table 86. Kissei Pharmaceutical Thrombopoiesis Stimulating Agents Product

Table 87. Kissei Pharmaceutical Revenue in Thrombopoiesis Stimulating Agents Business (2020-2025) & (US$ Million)

Table 88. Kissei Pharmaceutical Recent Development

Table 89. Grifols Company Details

Table 90. Grifols Business Overview

Table 91. Grifols Thrombopoiesis Stimulating Agents Product

Table 92. Grifols Revenue in Thrombopoiesis Stimulating Agents Business (2020-2025) & (US$ Million)

Table 93. Grifols Recent Development

Table 94. JW Pharmaceutical Corporation Company Details

Table 95. JW Pharmaceutical Corporation Business Overview

Table 96. JW Pharmaceutical Corporation Thrombopoiesis Stimulating Agents Product

Table 97. JW Pharmaceutical Corporation Revenue in Thrombopoiesis Stimulating Agents Business (2020-2025) & (US$ Million)

Table 98. JW Pharmaceutical Corporation Recent Development

Table 99. Medison Pharma Canada Company Details

Table 100. Medison Pharma Canada Business Overview

Table 101. Medison Pharma Canada Thrombopoiesis Stimulating Agents Product

Table 102. Medison Pharma Canada Revenue in Thrombopoiesis Stimulating Agents Business (2020-2025) & (US$ Million)

Table 103. Medison Pharma Canada Recent Development

Table 104. AstraZeneca Company Details

Table 105. AstraZeneca Business Overview

Table 106. AstraZeneca Thrombopoiesis Stimulating Agents Product

Table 107. AstraZeneca Revenue in Thrombopoiesis Stimulating Agents Business (2020-2025) & (US$ Million)

Table 108. AstraZeneca Recent Development

Table 109. Research Programs/Design for This Report

Table 110. Key Data Information from Secondary Sources

Table 111. Key Data Information from Primary Sources

Table 112. Authors List of This Report

List of Figures

Figure 1. Thrombopoiesis Stimulating Agents Picture

Figure 2. Global Thrombopoiesis Stimulating Agents Market Size Comparison by Type (2020-2031) & (US$ Million)

Figure 3. Global Thrombopoiesis Stimulating Agents Market Share by Type: 2024 VS 2031

Figure 4. Romiplostim Features

Figure 5. Fostamatinib Features

Figure 6. Mulpleta Features

Figure 7. Doptelet Features

Figure 8. Others Features

Figure 9. Global Thrombopoiesis Stimulating Agents Market Size by Application (2020-2031) & (US$ Million)

Figure 10. Global Thrombopoiesis Stimulating Agents Market Share by Application: 2024 VS 2031

Figure 11. Adults Case Studies

Figure 12. Pediatric Patients Case Studies

Figure 13. Thrombopoiesis Stimulating Agents Report Years Considered

Figure 14. Global Thrombopoiesis Stimulating Agents Market Size (US$ Million), Year-over-Year: 2020-2031

Figure 15. Global Thrombopoiesis Stimulating Agents Market Size, (US$ Million), 2020 VS 2024 VS 2031

Figure 16. Global Thrombopoiesis Stimulating Agents Market Share by Region: 2024 VS 2031

Figure 17. Global Thrombopoiesis Stimulating Agents Market Share by Players in 2024

Figure 18. Global Top Thrombopoiesis Stimulating Agents Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Thrombopoiesis Stimulating Agents as of 2024)

Figure 19. The Top 10 and 5 Players Market Share by Thrombopoiesis Stimulating Agents Revenue in 2024

Figure 20. North America Thrombopoiesis Stimulating Agents Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 21. North America Thrombopoiesis Stimulating Agents Market Share by Country (2020-2031)

Figure 22. United States Thrombopoiesis Stimulating Agents Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 23. Canada Thrombopoiesis Stimulating Agents Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 24. Europe Thrombopoiesis Stimulating Agents Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 25. Europe Thrombopoiesis Stimulating Agents Market Share by Country (2020-2031)

Figure 26. Germany Thrombopoiesis Stimulating Agents Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 27. France Thrombopoiesis Stimulating Agents Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 28. U.K. Thrombopoiesis Stimulating Agents Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 29. Italy Thrombopoiesis Stimulating Agents Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 30. Russia Thrombopoiesis Stimulating Agents Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 31. Nordic Countries Thrombopoiesis Stimulating Agents Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 32. Asia-Pacific Thrombopoiesis Stimulating Agents Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 33. Asia-Pacific Thrombopoiesis Stimulating Agents Market Share by Region (2020-2031)

Figure 34. China Thrombopoiesis Stimulating Agents Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 35. Japan Thrombopoiesis Stimulating Agents Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 36. South Korea Thrombopoiesis Stimulating Agents Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 37. Southeast Asia Thrombopoiesis Stimulating Agents Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 38. India Thrombopoiesis Stimulating Agents Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 39. Australia Thrombopoiesis Stimulating Agents Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 40. Latin America Thrombopoiesis Stimulating Agents Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 41. Latin America Thrombopoiesis Stimulating Agents Market Share by Country (2020-2031)

Figure 42. Mexico Thrombopoiesis Stimulating Agents Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 43. Brazil Thrombopoiesis Stimulating Agents Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 44. Middle East & Africa Thrombopoiesis Stimulating Agents Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 45. Middle East & Africa Thrombopoiesis Stimulating Agents Market Share by Country (2020-2031)

Figure 46. Turkey Thrombopoiesis Stimulating Agents Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 47. Saudi Arabia Thrombopoiesis Stimulating Agents Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 48. UAE Thrombopoiesis Stimulating Agents Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 49. Amgen Revenue Growth Rate in Thrombopoiesis Stimulating Agents Business (2020-2025)

Figure 50. Kyowa Kirin Revenue Growth Rate in Thrombopoiesis Stimulating Agents Business (2020-2025)

Figure 51. Intas Pharmaceuticals Revenue Growth Rate in Thrombopoiesis Stimulating Agents Business (2020-2025)

Figure 52. SHIONOGI Revenue Growth Rate in Thrombopoiesis Stimulating Agents Business (2020-2025)

Figure 53. Novartis Pharma Revenue Growth Rate in Thrombopoiesis Stimulating Agents Business (2020-2025)

Figure 54. AkaRx Revenue Growth Rate in Thrombopoiesis Stimulating Agents Business (2020-2025)

Figure 55. Rigel Pharmaceuticals Revenue Growth Rate in Thrombopoiesis Stimulating Agents Business (2020-2025)

Figure 56. Kissei Pharmaceutical Revenue Growth Rate in Thrombopoiesis Stimulating Agents Business (2020-2025)

Figure 57. Grifols Revenue Growth Rate in Thrombopoiesis Stimulating Agents Business (2020-2025)

Figure 58. JW Pharmaceutical Corporation Revenue Growth Rate in Thrombopoiesis Stimulating Agents Business (2020-2025)

Figure 59. Medison Pharma Canada Revenue Growth Rate in Thrombopoiesis Stimulating Agents Business (2020-2025)

Figure 60. AstraZeneca Revenue Growth Rate in Thrombopoiesis Stimulating Agents Business (2020-2025)

Figure 61. Bottom-up and Top-down Approaches for This Report

Figure 62. Data Triangulation

Figure 63. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Thrombocyte Shakers Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Blood Platelet Incubator Market Research Report 2025

Global Macrophage Stimulating Protein Receptor Market Research Report 2025

Global Thrombocytes Market Research Report 2025

Plasma Incubators Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Hemostatic Agents Market Research Report 2025

Hematopoietic Progenitor Cells Transplantation Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Platelet Laboratory Incubator Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Blood Platelets Market Research Report 2025

Phosphate Free Chelating Agent Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Angiopoietin 2 Market Research Report 2025

Blood Vessels Embolic Agents Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Floor standing Platelet Laboratory Incubator Market

Platelet Concentration Systems Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Platelet Agitators Market Research Report 2025

Global Platelet Rich Plasma Injection Market Research Report 2025

Platelet Rich Plasma Treatment Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Platelet Regeneration in Vitro Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Mobile Platelet Collection System Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

RELATED REPORTS

Global Geriatric Care Services Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-17Q6174

Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Hospice Software Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-8Z4276

Thu Sep 11 00:00:00 UTC 2025

Add to Cart

Global Geriatric Care Devices Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-8Q8325

Thu Sep 11 00:00:00 UTC 2025

Add to Cart

Global Allied Health Care Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-29V19536

Thu Sep 11 00:00:00 UTC 2025

Add to Cart

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions